Daily Podcasts Video Research

One step closer to a cure for Alzheimer's? A Canadian expert weighs in

star 0 Science Culture

JL;DR SUMMARY In this episode, Dr. Sharon Cohen discusses the significance of aducanumab, a newly FDA-approved drug for Alzheimer's, which while promising, raises concerns regarding side effects and efficacy. A way out west there was a fella, fella I want to tell you about, fella by the name of Jeff Lebowski.

  • At least, that was the handle his lovin' parents gave him, but he never had much use for it himself.
  • This Lebowski, he called himself the Dude.
  • Now, Dude, that's a name no one would self-apply where I come from.
  • But then, there was a lot about the Dude that didn't make a whole lot of sense to me.
  • And a lot about where he lived, likewise. But then again, maybe that's why I found the place s'durned innarestin'.
JL;DR members get full summaries and key points of all podcast episodes in the archive, including this one. Donate & listen smarter »

Tags

Lifestyle ChangesAlzheimer'sFda ApprovalNeurologyBrain HealthAducanumabDr. Sharon CohenToronto Memory ProgramAmyloidEarly Diagnosis

Places mentioned

No places identified yet.
This podcast episode was indexed and curated by Cairo, JL;DR's web crawler.
Cairo Item ID 23773
Cairo Source ID 72
Retrieved 2024-05-23 16:41:17 UTC
Curated 2024-08-29 19:20:20 UTC